High Prevalence of strongyloidiasis in Spain: a hospital-based study

dc.contributor.authorRequena-Méndez, Ana
dc.contributor.authorSalas-Coronas, Joaquín
dc.contributor.authorSalvador, Fernando
dc.contributor.authorGomez-Junyent, Joan
dc.contributor.authorVillar García, Judit
dc.contributor.authorSantín, Miguel
dc.contributor.authorMuñoz, Carme
dc.contributor.authorGonzález-Cordón, Ana
dc.contributor.authorCabezas Fernández, Maria Teresa
dc.contributor.authorSulleiro, Elena
dc.contributor.authorArenas-Miras, María Del Mar
dc.contributor.authorSomoza, Dolors
dc.contributor.authorVazquez-Villegas, Jose
dc.contributor.authorTreviño, Begoña
dc.contributor.authorRodríguez, Esperanza
dc.contributor.authorValls, Maria Eugenia
dc.contributor.authorLlaberia-Marcual, Jaume
dc.contributor.authorSubirá, Carme
dc.contributor.authorMuñoz, José
dc.date.accessioned2021-04-26T07:30:36Z
dc.date.available2021-04-26T07:30:36Z
dc.date.issued2020
dc.description.abstractIntroduction: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. Methods: This study aims at evaluating the prevalence of S. stercoralis at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for S. stercoralis infection using serological tests was offered to all eligible participants. Results: The overall seroprevalence of S. stercoralis was 9.04% (95%CI 7.76-10.31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9.35% (95%CI 7.01-11.69), 9.22% (7.5-10.93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2.9% (95%CI -0.3-6.2). The seroprevalence in units attending potentially immunosuppressed patients was significantly lower (5.64%) compared with other units of the hospital (10.20%) or Tropical diseases units (13.33%) (p < 0.001). Conclusions: We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression.
dc.format.mimetypeapplication/pdf
dc.identifier.citationRequena-Méndez A, Salas-Coronas J, Salvador F, Gomez-Junyent J, Villar-Garcia J, Santin M, et al. High Prevalence of strongyloidiasis in Spain: a hospital-based study. Pathogens. 2020 Feb 11; 9(2): 107. DOI: 10.3390/pathogens9020107
dc.identifier.doihttp://dx.doi.org/10.3390/pathogens9020107
dc.identifier.issn2076-0817
dc.identifier.urihttp://hdl.handle.net/10230/47194
dc.language.isoeng
dc.publisherMDPI
dc.rightsCopyright © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.keywordSpain
dc.subject.keywordStrongyloides stercoralis
dc.subject.keywordMigrants
dc.subject.keywordPrevalence
dc.subject.keywordStrongyloidiasis
dc.titleHigh Prevalence of strongyloidiasis in Spain: a hospital-based study
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
requena-pat-high.pdf
Size:
740.41 KB
Format:
Adobe Portable Document Format

License

Rights